amifostine anhydrous has been researched along with acetylcysteine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lockhart, SP | 1 |
| Davis, HD; Dominitz, JA; Landauer, MR; Weiss, JF | 1 |
| Schor, NF | 1 |
| Sedlacek, R; Verhey, LJ | 1 |
| Kachel, DL; Martin, WJ | 1 |
| Ameglio, F; Bonanno, G; Capoluongo, E; Leone, G; Marone, M; Pierelli, L; Rumi, C; Rutella, S; Scambia, G; Sica, S | 1 |
| Jackson, W; Kumar, KS; Seed, TM; Singh, VK | 1 |
| Anfossi, G; Massucco, P; Mattiello, L; Russo, I; Trovati, M | 1 |
| Cao, D; Grdina, DJ; Kataoka, Y; Li, JJ; Murley, JS; Oberley, LW | 1 |
| Bowen, JM; Keefe, DM; Sonis, ST | 1 |
| Rosenthal, DI; Trotti, A | 1 |
| Ayaz, L; Demirel, C; Erdal, N; Gürgül, S; Kilciksiz, S; Ors, Y; Tamer, L | 1 |
| Karabay, G; Kıray, S; Kuscu, E; Onalan, G; Zeyneloglu, H | 1 |
| Dagdeviren, A; Gulumser, C; Mulayim, B; Onalan, G; Zeyneloglu, H | 1 |
| Grdina, DJ; Miller, RC; Murley, JS | 1 |
| Akbulut, S; Dogan, Z; Elbe, H; Erdemli, E; Eris, C; Otan, E; Toprak, G; Turkoz, Y | 1 |
| Arman, Ö; Emir, S; Özbek, N; Özyörük, D; Tunç, B | 1 |
| Brock, P; Cabral, S; Freyer, DR; Knight, K; Reaman, G; Robinson, PD; Sung, L | 1 |
4 review(s) available for amifostine anhydrous and acetylcysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Emerging drugs for chemotherapy-induced mucositis.
Topics: Acetylcysteine; Amifostine; Antineoplastic Agents; Drugs, Investigational; Fibroblast Growth Factor 7; Glutamine; Humans; Mucositis; Palliative Care | 2008 |
Strategies for managing radiation-induced mucositis in head and neck cancer.
Topics: Acetylcysteine; Amifostine; Carcinoma, Squamous Cell; Glutamine; Head and Neck Neoplasms; Humans; Intercellular Signaling Peptides and Proteins; Low-Level Light Therapy; Mouthwashes; Oral Hygiene; Pain Management; Risk Factors; Stomatitis | 2009 |
Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.
Topics: Acetylcysteine; Adolescent; Amifostine; Anti-Inflammatory Agents; Antineoplastic Agents; Chelating Agents; Child; Cisplatin; Cytoprotection; Dexamethasone; Disulfiram; Ditiocarb; Humans; Neoplasms; Ototoxicity; Thiosulfates | 2019 |
17 other study(ies) available for amifostine anhydrous and acetylcysteine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Inhaled thiol and phosphorothiol radioprotectors fail to protect the mouse lung.
Topics: Acetylcysteine; Administration, Inhalation; Aerosols; Amifostine; Animals; Cysteamine; Lung; Male; Mice; Mice, Inbred CBA; Radiation Injuries, Experimental | 1990 |
Comparative behavioral toxicity of four sulfhydryl radioprotective compounds in mice: WR-2721, cysteamine, diethyldithiocarbamate, and N-acetylcysteine.
Topics: Acetylcysteine; Amifostine; Animals; Cysteamine; Ditiocarb; Drug Evaluation, Preclinical; Male; Mice; Mice, Inbred BALB C; Motor Activity; Radiation-Protective Agents; Sulfhydryl Compounds | 1988 |
Mechanisms of synergistic toxicity of the radioprotective agent, WR2721, and 6-hydroxydopamine.
Topics: Acetylcysteine; Amifostine; Animals; Catalase; Drug Synergism; Eating; Free Radicals; Glutamate-Cysteine Ligase; Glutathione; Hydroxydopamines; Magnesium; Mercaptoethylamines; Mice; Mice, Inbred A; Organothiophosphorus Compounds; Oxidopamine; Peptide Synthases; Superoxide Dismutase; Time Factors | 1988 |
Determination of the radioprotective effects of topical applications of MEA, WR-2721, and N-acetylcysteine on murine skin.
Topics: Acetylcysteine; Administration, Topical; Amifostine; Animals; Carbon Dioxide; Cysteamine; Dose-Response Relationship, Radiation; Female; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred C3H; Organothiophosphorus Compounds; Oxygen; Radiotherapy; Skin | 1983 |
Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury.
Topics: Acetylcysteine; Amifostine; Animals; Biotransformation; Cattle; Cells, Cultured; Cyclophosphamide; Drug Interactions; Endothelium, Vascular; Lung; Pulmonary Artery | 1994 |
T-cell apoptosis induced by granulocyte colony-stimulating factor is associated with retinoblastoma protein phosphorylation and reduced expression of cyclin-dependent kinase inhibitors.
Topics: Acetylcysteine; Adult; Amifostine; Antioxidants; Apoptosis; Carrier Proteins; Caspase 3; Caspases; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; DNA Fragmentation; Enzyme Inhibitors; Female; G1 Phase; Gene Expression; Granulocyte Colony-Stimulating Factor; Humans; Lymphocyte Count; Male; Microtubule-Associated Proteins; Mitochondria; Phosphorylation; Reactive Oxygen Species; Retinoblastoma Protein; T-Lymphocytes; Tumor Suppressor Proteins | 2001 |
Inhibition of LPS-induced nitric oxide production in RAW cells by radioprotective thiols.
Topics: Acetylcysteine; Amifostine; Animals; Cell Line; Cysteine; Disulfiram; Dithiothreitol; Lipopolysaccharides; Macrophages; Mercaptoethylamines; Mice; Nitric Oxide; Radiation-Protective Agents; Sulfhydryl Compounds | 2003 |
Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects.
Topics: Acetylcysteine; Adenosine Diphosphate; Adult; Amifostine; Antioxidants; Collagen; Cyclic GMP; Drug Resistance; Female; Free Radical Scavengers; Humans; Insulin Resistance; Male; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Obesity; Platelet Aggregation; Platelet Aggregation Inhibitors; Superoxide Dismutase | 2003 |
Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs.
Topics: Acetylcysteine; Amifostine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Captopril; Cell Line, Tumor; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; I-kappa B Proteins; Mercaptoethylamines; Mesna; Mice; Mutation; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Plasmids; Protective Agents; Radiation-Protective Agents; Serine; Sulfhydryl Compounds; Superoxide Dismutase; Time Factors; Transfection | 2004 |
The effect of N-acetylcysteine on biomarkers for radiation-induced oxidative damage in a rat model.
Topics: Acetylcysteine; Amifostine; Animals; Biomarkers; Female; Free Radical Scavengers; Glutathione; Liver; Malondialdehyde; Oxidative Stress; Peroxidase; Radiation Dosage; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Rats, Wistar | 2008 |
Antioxidant prophylaxis for cellular injury in ovarian surface epithelium resulting from CO₂ pneumoperitoneum in a laparoscopic rat model.
Topics: Acetylcysteine; Amifostine; Animals; Antioxidants; Carbon Dioxide; Epithelium; Female; Free Radical Scavengers; Laparoscopy; Ovary; Oxidative Stress; Pneumoperitoneum, Artificial; Preoperative Care; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Vitamin E | 2011 |
Effects of amifostine on endometriosis, comparison with N-acetyl cysteine, and leuprolide as a new treatment alternative: a randomized controlled trial.
Topics: Abdominal Wall; Acetylcysteine; Amifostine; Animals; Disease Models, Animal; Endometriosis; Endometrium; Female; Leuprolide; Peritoneal Diseases; Peritoneum; Random Allocation; Rats; Rats, Wistar; Treatment Outcome | 2014 |
Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs.
Topics: Acetylcysteine; Acute Radiation Syndrome; Amifostine; Animals; Captopril; Cell Line, Transformed; Cell Line, Tumor; Cells, Cultured; Colony-Forming Units Assay; Drug Evaluation, Preclinical; Drug Synergism; Endothelial Cells; Fibroblasts; Free Radical Scavengers; Humans; Mesna; Metformin; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Radiation Injuries, Experimental; Radiation-Protective Agents; Sarcoma; Sulfhydryl Compounds | 2014 |
Cytoprotective effects of amifostine, ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats.
Topics: Acetylcysteine; Amifostine; Animals; Antioxidants; Ascorbic Acid; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Liver; Male; Methotrexate; Oxidative Stress; Rats, Sprague-Dawley; Time Factors | 2014 |
Accidental cisplatin overdose in a child: Successful management with repetitive plasmapheresis and use of chemoprotective agents.
Topics: Acetylcysteine; Adolescent; Amifostine; Antineoplastic Agents; Cisplatin; Drug Overdose; Female; Humans; Plasmapheresis | 2016 |